anacor pharmaceuticals inc
(ANAC:Consolidated Issue listed on NASDAQ Global Market)
David P. Perry M.B.A.
Former Chief Executive Officer, President and Director, Anacor Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 2 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. David P. Perry, M.B.A. has been Chief Executive Officer and President of Symbiota, Inc. since January 7, 2015. Mr. Perry served as the Chief Executive Officer and President of Anacor Pharmaceuticals Inc. from March 2002 to March 19, 2014. He served as Chief Executive Officer of Chemdex. Mr. Perry co-founded NexPrise, Inc. in September 1997 and served as its President and Chief Executive Officer until November 2001. He co-founded Virogen Inc., a biotechnology company ...
1020 East Meadow CirclePhone: 650-543-7500
Palo Alto, California 94303
Board Members Memberships*
Vice Chairman of the Board
Former Chief Executive Officer, President and Director
University of Tulsa
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|